发明名称 |
Composto, processo para preparar o enanciômero puro, composição farmacêutica, uso do enanciômero puro, métodos para prevenir ou tratar doença em um animal de sangue quente, e, combinação |
摘要 |
<p>The present invention relates to enantiomerically pure (-) 2-[1-(7-methyl-2-(morpholin-4-yl)-4-oxo-4H-pyrido[1,2-a]pyrimidin-9-yl)ethylamino]benzoic acid or pharmaceutically acceptable salts thereof, it being in a solid state, its use in medical therapy, pharmaceutical composition comprising it, its use in the preparation of a medicament for use in a method for preventing or treating diseases, and its use in method for preventing or treating disease. The present invention relates to a selective inhibitor of phosphoinositide (PI) 3-kinase beta and use of the selective inhibitor in e.g. anti-thrombotic therapy.</p> |
申请公布号 |
BRPI0906805(A2) |
申请公布日期 |
2015.07.14 |
申请号 |
BR2009PI06805 |
申请日期 |
2009.01.22 |
申请人 |
ASTRAZENECA AB |
发明人 |
OLA FJELLSTRÖM;DAVID GUSTAFSSON;JAN A LINDBERG;SHAUN JACKSON |
分类号 |
C07D471/04;A61K31/519;A61K31/5377;A61P7/02;A61P9/10;A61P11/00;A61P35/00 |
主分类号 |
C07D471/04 |
代理机构 |
|
代理人 |
|
主权项 |
|
地址 |
|